Wanbury is all set to launch two new products, for formulation (Branded generic) div., Branded Hematinic Iron tablets WANBURY C-RED and for API (Bulk Drug) div - launching KETAMINE HYDROCHLORIDE.
Wanbury held strong equity in gynecology segment, to capitalize on the same, the company is launching -- WANBURY C-RED. It is an iron supplement, which helps improving hemoglobin in the blood of individuals especially during pregnancy. The Ketamine is developed by a unique cost competitive process & quality product by In - house R&D team in compliance with all the major pharmacopeia such as USP & EP. Ketamine has annual demand of over 200 tons for both human and veterinary market. Ketamine is used to promote sleep before & during surgeries. The company is commencing supply of Ketamine during this month with export for European markets.
Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.
